跳至主要内容
临床试验/NCT03112187
NCT03112187已完成4 期

FLIPS: Ferfer Liposomal Iron Performance Study

PharmEvo Pvt Ltd1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2017年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
400
试验地点
1
主要终点
Efficacy of a novel food supplement, Ferfer® to raise the capacity of Haemoglobin levels

研究概览

简要总结

To evaluate the efficacy of a novel food supplement, Ferfer® to raise the capacity of Haemoglobin and Haematocrit levels

详细描述

Anemia, described as a low blood Haemoglobin concentration, has been shown to be a public health problem that impacts low-, center- and high-earnings nations and has great unfavorable health results, as well as unfavorable influences on social and monetary development . even though the most dependable indicator of anemia on the populace stage is blood Haemoglobin attention, measurements of this attention by myself do now not determine the cause of anemia. Anemia may additionally result from a number of causes, with the maximum great contributor being iron deficiency. approximately 30%- 50% of instances of anemia are taken into consideration to be because of iron deficiency.

Doctor will evaluate on the basis of inclusion or exclusion criteria, lab values and overall assessment and then enroll in this clinical trial. During the study patient will visit the Doctor four times, Day 0 week 4, week 8 and week 12. Doctor will investigate the Hemoglobin level and Hematocrit level and also evaluate the adverse effects and tolerability of Ferfer® at week 2 and week 8. Doctor also instructed to take the food supplements, twice daily, once in a morning and once in evening independently by food intake as Ferfer® has no interaction with food.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Iron deficiency anemia (Hemoglobin <8 to >5 g/dl)
  • Subjects able to provide written informed consent;
  • Subjects already treated with other iron supplements or drugs that experienced side effects (not including allergy) related to iron administration.
  • Wash out period will be a week

排除标准

  • Had a history of iron intolerance
  • Hypersensitivity and allergic of Vit C and Vit B12
  • Not willing to take informed consent

研究组 & 干预措施

Intervention

Experimental

Ferfer is a food supplement in liposomal form, with essential, vitamins including Vitamin C and Vitamin B12. Ferfer directly dissolves in the mouth without the need for water. The technology of liposomal microencapsulation, allows daily iron supplementation without any of the typical side effects of conventional oral iron supplements, such as heartburn, diarrhea, constipation, nausea and coloring of the mucous membranes and of the stools, which increases patient compliance. It has no metallic taste or smell, does not color mucous membrane and has excellent tolerability

干预措施: Iron Supplement (Drug)

结局指标

主要结局

Efficacy of a novel food supplement, Ferfer® to raise the capacity of Haemoglobin levels

时间窗: Week 12

To determine the efficacy of a novel food supplement,Ferfer® to raise the capacity of Haemoglobin levels Designated as safety issue: No

次要结局

  • Adverse Event(upto 12 weeks)
  • Efficacy of a novel food supplement, Ferfer® to raise the capacity of ferritin levels(Week 12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验